Session Statistics
The following abstract statistics are available from the 2010 Annual Meeting:
| Abstract Totals |
Count |
| Abstracts Submitted |
5149 |
| Abstracts Accepted for Presentation |
2976 (57.8%) |
- Oral Presentation
(Plenary, Clinical Science Symposia, Oral Abstract Session) |
265 (8.9%) |
|
- Poster Presentation
(Poster Discussion, General Poster, Trials in Progress)
|
2711 (91.1%) |
| Online Publication Only |
1682 (32.7%) |
| Rejected |
247 (4.8%) |
| Withdrawn |
244 (4.7%) |
Abstract Submissions by Country:
| Top 10 Countries: |
Count |
| United States |
2316 |
| Italy |
289 |
| Germany |
274 |
| Japan |
246 |
| France |
241 |
| Canada |
191 |
| Spain |
172 |
| United Kingdom |
166 |
| South Korea |
121 |
| China |
99 |
Abstract Submissions by Track:
|
Abstracts |
| Track |
Submitted |
Accepted for Presentation |
| Breast Cancer - Local-Regional and Adjuvant Therapy |
320 |
201 (62.8%) |
| Breast Cancer - Metastatic Breast Cancer |
206 |
176 (85.4%) |
| Cancer Prevention/Epidemiology |
181 |
108 (60%) |
| Central Nervous System Tumors |
182 |
106 (58.2%) |
| Developmental Therapeutics - Clinical Pharmacology and Immunotherapy |
305 |
135 (44.2%) |
| Developmental Therapeutics - Experimental Therapeutics |
300 |
122 (40.7%) |
| Gastrointestinal (Colorectal) Cancer |
334 |
167 (50%) |
| Gastrointestinal (Noncolorectal) Cancer |
414 |
188 (45.4%) |
| Genitourinary Cancer |
399 |
214 (53.6%) |
| Gynecologic Cancer |
209 |
133 (63.65) |
| Head and Neck Cancer |
155 |
111 (71.6%) |
| Health Services Research |
290 |
162 (55.9%) |
| Leukemia, Myelodysplasia, and Transplantation |
131 |
121 (92.4%) |
| Lung Cancer - Local-Regional and Adjuvant Therapy |
143 |
102 (71.3%) |
| Lung Cancer - Metastatic |
303 |
143 (47.2%) |
| Lymphoma and Plasma Cell Disorders |
234 |
164 (70%) |
| Melanoma/Skin Cancers |
144 |
104 (72.2%) |
| Patient and Survivor Care |
383 |
177 (46.2%) |
| Pediatric Oncology |
97 |
84 (86.6%) |
| Sarcoma |
136 |
104 (76.5%) |
| Tumor Biology |
283 |
154 (54.4%) |